India link in fresh US insider trading scam
- No resignations, BJP prepares for stormy Monsoon session
- IPL GC meet: Thakur-Shirke want CSK, RR scrapped; Shukla-Shastri say no
- Arvind Kejriwal to PM: Devote time to Delhi Police or hand over its charge
- Two killed in landslide on Mumbai-Pune Expressway, traffic comes to halt
- IIT Delhi's decision to invite Ramdev raises eyebrows
A prominent Indian-origin hedge fund portfolio manager has been charged with participating in one of the "most lucrative" insider trading schemes ever in the US.
Mathew Martoma, 38, has been charged with using material, non-public information that he received from a doctor on the clinical trial of an Alzheimer's drug to make profits and avoid losses for his hedge fund for an amount totalling approximately $276 million.
Martoma, who was arrested last week from his home in Boca Raton, Florida, was released on Monday on a $5 million bail after a brief hearing at the Manhattan federal court here. He did not enter any plea and the judge set the next hearing for December 26.
The US Securities and Exchange Commission has also filed a civil insider trading case against him.